Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2013
05/08/2013CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof
05/08/2013CN103086984A 4-phenylamino quinazoline derivative, preparation method and application thereof
05/08/2013CN103086973A Preparation method of terminal alkyne based pyrazol compound
05/08/2013CN103086953A Heterocyclic compound and organic light-emitting device including the same
05/08/2013CN103086949A Carbazole derivatives and organic light emitting diodes comprising the same
05/08/2013CN103086942A Heterocyclic compound and organic light-emitting diode comprising the same
05/08/2013CN102241665B 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof
05/08/2013CN101821236B Five-membered heterocyclic compound
05/08/2013CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
05/08/2013CN101578265B Sulfonamide derivatives as chymase inhibitors
05/08/2013CN101218224B Compounds and methods for the treatment or prevention of flavivirus infections
05/08/2013CN101203509B Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
05/07/2013US8435976 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
05/07/2013CA2694911C Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
05/07/2013CA2598460C Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
05/07/2013CA2575073C Fungicidal composition containing acid amide derivative
05/07/2013CA2551956C Selective estrogen receptor modulators for the treatment of vasomotor symptoms
05/07/2013CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/02/2013WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013WO2013062043A1 4-aminocarbazole compound and use of same
05/02/2013WO2013061973A1 Heteroaryl sulfonamide compound or salt thereof
05/02/2013WO2013061850A1 Organic electroluminescence element, display device, and lighting device
05/02/2013WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013WO2013061004A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013061002A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity
05/02/2013WO2013060751A1 Novel pyrazine derivatives
05/02/2013WO2013059928A1 Hiv protease inhibitors
05/02/2013WO2013036912A3 Amido compounds as rorϒtmodulators and uses thereof
05/02/2013WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
05/02/2013US20130109715 6-Substituted isoquinolines and isoquinolinones
05/02/2013US20130109695 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
05/02/2013US20130109687 Methods of treating hiv infection: inhibition of dna dependent protein kinase
05/02/2013US20130109652 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/02/2013US20130108605 Method of ameliorating oxidative stress and supplementing the diet
05/02/2013CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative
05/02/2013CA2852404A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013CA2851930A1 Novel pyrazine derivatives
05/02/2013CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013CA2848263A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/01/2013EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors
05/01/2013EP2585470A2 Novel fused pyrimidine derivatives for inhd3ition of tyrosine kinase activity
05/01/2013EP2585447A2 Compounds and methods for the treatment or prevention of flavivirus infections
05/01/2013EP2585443A1 Process for producing imine compounds for combating invertebrate pests
05/01/2013CN103081155A Light-emitting element
05/01/2013CN103080105A Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics
05/01/2013CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
05/01/2013CN103080103A Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
05/01/2013CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders
05/01/2013CN103080086A Prostaglandin D synthase inhibitory piperidine compounds
05/01/2013CN103079406A Fungicidal pyrazoles
05/01/2013CN101861307B Certain substituted amides, method of making, and method of use thereof
05/01/2013CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof
05/01/2013CN101365687B Piperazine compounds with a herbicidal action
04/2013
04/30/2013US8431573 Cyanopyrimidinones
04/30/2013US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
04/30/2013US8431250 Aromatic amine derivative, and organic electroluminescent element comprising the same
04/30/2013CA2599425C Substituted gamma lactams as therapeutic agents
04/30/2013CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors
04/30/2013CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors
04/25/2013WO2013059222A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
04/25/2013WO2013058258A1 Bicyclic heterocyclic compound
04/25/2013WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes
04/25/2013WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/25/2013WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7
04/25/2013WO2012122340A8 Soluble guanylate cyclase activators
04/25/2013US20130102785 Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling
04/25/2013US20130102619 2-pyridyloxy-4-nitrile orexin receptor antagonists
04/25/2013US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions
04/25/2013US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders
04/25/2013US20130102592 Oxazole tyrosine kinase inhibitors
04/25/2013US20130102585 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/25/2013US20130102462 Process for Producing Imine Compounds for Combating Invertebrate Pests
04/25/2013US20130099208 Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound
04/25/2013US20130099171 Materials for organic electroluminescent devices
04/25/2013CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/25/2013CA2852425A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
04/25/2013CA2851589A1 Bicyclic heterocyclic compound
04/24/2013EP2583963A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain
04/24/2013EP2583956A2 A method of preparation of polycyclic, fused aromatic and heteroaromatic hydrocarbons and intermediates
04/24/2013EP2582695A1 Anthranilic acid diamide derivatives with cyclical side chains
04/24/2013CN1653050B Opioid and opioid-like compounds and uses thereof
04/24/2013CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
04/24/2013CN103068804A Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
04/24/2013CN103068798A Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
04/24/2013CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
04/24/2013CN103058995A Quinazolinyl piperazine derivative and purpose thereof
04/24/2013CN103058987A Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound
04/24/2013CN103058938A 4-aniline quinazoline compound substituting cinnamic acid, and preparation method and application thereof
04/24/2013CN101863923B Novel inhibitors of chymase
04/24/2013CN101787013B Novel lipoamide derivatives and preparation method and pharmaceutical application thereof
04/23/2013US8426424 Certain substituted amides, method of making, and method of use thereof
04/23/2013CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
04/23/2013CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
04/23/2013CA2552419C Azadecalin glucocorticoid receptor modulators
04/23/2013CA2538906C Process for preparing 4-(4-aminophenyl)-3-morpholinone
04/23/2013CA2471355C Substituted diketopiperazines as oxytocin antagonists
04/18/2013WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
04/18/2013WO2013055793A1 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 523